Table 2 Demographic and clinical characteristics of drug resistance TB patients
Variables, n (%) | DR-TB (n = 57) | DS-TB (n = 30) | OR (95% C.I) for DR-TB | p values |
|---|---|---|---|---|
Gender | ||||
 Male | 26 | 14 | o.96 (0.36–2.56) | 0.93 |
 Female | 31 | 16 |  |  |
Age (years) | ||||
  < 33 | 21 | 10 |  |  |
  ≥ 33 | 36 | 20 | 1.17 (0.42–3.34) | 0.55 |
HIV status | ||||
 Negative | 41 | 26 | 2.5 (0.70–11.47) | 0.12 |
 Positive | 16 | 4 |  |  |
CD4 count (n = 20) | ||||
  < 200 | 6 | 2 |  |  |
  ≥ 200 | 10 | 2 | 0.6 (0.04–10.62) | 0.65 |
Previous history of TB treatment | ||||
 New | 16 | 29 | 0.01 (0.0003–0.0995) | <0.001 |
 Retreatment | 41 | 1 |  |  |
Body mass index | ||||
  < 16–18.5 | 19 | 7 |  |  |
  ≥ 18.5 | 38 | 23 | 1.6 (0.55–5.34) | 0.33 |